{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:11:50Z","timestamp":1778645510432,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014795","name":"Center of Excellence for Innovation in Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007288","name":"Mahasarakham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016204","name":"Ministry of Higher Education, Science, Research and Innovation, Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmgm.2026.109289","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:12:03Z","timestamp":1768263123000},"page":"109289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a novel PI3K\u03b1 inhibitor for breast cancer therapy via virtual screening method, molecular dynamics simulation and biological evaluation"],"prefix":"10.1016","volume":"144","author":[{"given":"Thitiya","family":"Boonma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodee","family":"Nutho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phongthon","family":"Kanjanasirirat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chananya","family":"Rajchakom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadtanet","family":"Nunthaboot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109289_bib1","article-title":"In silico molecular docking studies and MM\/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer, beni-suef univ. J","volume":"9","author":"Pattar","year":"2020","journal-title":"Basic Appl. Sci."},{"key":"10.1016\/j.jmgm.2026.109289_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100913","article-title":"P110\u03b1 inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer","volume":"43","author":"Chen","year":"2023","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biom9030082","article-title":"Structural determinants of isoform selectivity in PI3K inhibitors","volume":"9","author":"Miller","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2026.109289_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/BST0370615","article-title":"Form and flexibility in phosphoinositide 3-kinases","volume":"37","author":"Williams","year":"2009","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109289_bib7","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1039\/C8SC04498H","article-title":"The mechanism of PI3K\u03b1 activation at the atomic level","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109289_bib8","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11030-023-10695-7","article-title":"Structure-based pharmacophore modeling and DFT studies of Indian Ocean-derived red algal compounds as PI3K\u03b1 inhibitors","volume":"28","author":"Vasuki","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109289_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02072-1","article-title":"Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jmgm.2026.109289_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13543776.2024.2338100","article-title":"Targeting the PI3K\/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020\u20132023)","volume":"34","author":"Sabbah","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109289_bib11","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1080\/07391102.2020.1771421","article-title":"Identification of novel potential PI3K\u03b1 inhibitors for cancer therapy","volume":"39","author":"Zhang","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00204-023-03440-4","article-title":"Development and safety of PI3K inhibitors in cancer","volume":"97","author":"Yu","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9030024","article-title":"Class (I) phosphoinositide 3-kinases in the tumor microenvironment","volume":"9","author":"Gyori","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109289_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2019.02.002","article-title":"PIK3CA in cancer: the past 30 years","volume":"59","author":"Arafeh","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jmgm.2026.109289_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103334","article-title":"PI3K inhibition in breast cancer: identifying and overcoming different flavors of resistance","volume":"162","author":"Vitale","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"41","key":"10.1016\/j.jmgm.2026.109289_bib16","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jmgm.2026.109289_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.111.072546","article-title":"Isoform-selective inhibition of phosphoinositide 3-kinase: identification of a new Region of nonconserved amino acids critical for p110\u03b1 inhibition","volume":"80","author":"Zheng","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109289_bib18","doi-asserted-by":"crossref","DOI":"10.21037\/tbcr-24-29","article-title":"Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy","volume":"5","author":"Han","year":"2024","journal-title":"Transl. Breast. Cancer Res."},{"key":"10.1016\/j.jmgm.2026.109289_bib19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40265-019-01161-6","article-title":"Alpelisib: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2026.109289_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-024-02136-y","article-title":"Inavolisib: first approval","volume":"85","author":"Blair","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2026.109289_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s10822-024-00580-2","article-title":"Identification of novel inhibitors targeting PI3K\u03b1 via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation","volume":"38","author":"Zhang","year":"2024","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109289_bib22","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11030-023-10727-2","article-title":"Identification of natural product as selective PI3K\u03b1 inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations","volume":"28","author":"Halder","year":"2024","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109289_bib23","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s11030-023-10799-0","article-title":"A deep learning-based theoretical protocol to identify potentially isoform-selective PI3K\u03b1 inhibitors","volume":"28","author":"Shafiq","year":"2024","journal-title":"Mol. Divers."},{"issue":"33","key":"10.1016\/j.jmgm.2026.109289_bib24","doi-asserted-by":"crossref","first-page":"21452","DOI":"10.1039\/D2RA03451D","article-title":"Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3K\u03b1 against non-small cell lung cancer: a computational study","volume":"12","author":"Halder","year":"2022","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109289_bib25","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","article-title":"Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation","volume":"23","author":"Furet","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2026.109289_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109289_bib27","doi-asserted-by":"crossref","first-page":"W665","DOI":"10.1093\/nar\/gkh381","article-title":"PDB2PQR: an automated pipeline for the setup of poisson-boltzmann electrostatics calculations","volume":"32","author":"Dolinsky","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109289_bib28","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"15","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"issue":"28","key":"10.1016\/j.jmgm.2026.109289_bib29","doi-asserted-by":"crossref","first-page":"24511","DOI":"10.1021\/acsomega.2c02163","article-title":"Antidiabetic and cytotoxic activities of rotenoids and isoflavonoids isolated from Millettia pachycarpa benth","volume":"7","author":"Suthiphasilp","year":"2022","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109289_bib30","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1021\/acs.jnatprod.9b00506","article-title":"Dasymaschalolactams A-E, aristolactams from a twig extract of Dasymaschalon dasymaschalum","volume":"82","author":"Suthiphasilp","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27031088","article-title":"Four new anthraquinones with histone deacetylase inhibitory activity from Ventilago denticulata roots","volume":"27","author":"Hangsamai","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/13880209.2012.734314","article-title":"Antiproliferative effect of alkaloids via cell cycle arrest from Pseuduvaria rugosa","volume":"51","author":"Uadkla","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jmgm.2026.109289_bib33","article-title":"A new apotirucallane from Walsura trichostemon leaves and its antibacterial and \u03b1-Glucosidase inhibitory activities","volume":"17","author":"Suchaichit","year":"2021","journal-title":"Chem. Biodivers."},{"issue":"6","key":"10.1016\/j.jmgm.2026.109289_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2306\/scienceasia1513-1874.2013.39.610","article-title":"Anti-inflammatory and anticancer activities of (-)-zeylenol from stems of uvaria grandiflora","volume":"39","author":"Seangphakdeea","year":"2013","journal-title":"Sci. Asia"},{"issue":"10","key":"10.1016\/j.jmgm.2026.109289_bib35","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/np900352n","article-title":"Cytotoxic and antiplasmodial compounds from the roots of Strophioblachia fimbricalyx","volume":"72","author":"Seephonkai","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jmgm.2026.109289_bib36","article-title":"Neuroprotective and anticancer effects of 7-Methoxyheptaphylline via the TAK1 pathway","volume":"49","author":"Boonyarat","year":"2023","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109289_bib37","doi-asserted-by":"crossref","DOI":"10.48048\/tis.2024.7807","article-title":"Anticancer identification and molecular docking of cowanol from Garcinia fusca against histone deacetylase domains","volume":"21","author":"Punpai","year":"2024","journal-title":"Trends Sci."},{"key":"10.1016\/j.jmgm.2026.109289_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2026.109289_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jmgm.2026.109289_bib42","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109289_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0975-1483.100027","article-title":"Molecular docking and prediction of pharmacokinetic properties of dual mechanism drugs that block MAO-B and adenosine A(2A) receptors for the treatment of Parkinson's disease","volume":"4","author":"Azam","year":"2012","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.jmgm.2026.109289_bib45","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109289_bib46","series-title":"AMBER 2020","author":"Case","year":"2020"},{"issue":"8","key":"10.1016\/j.jmgm.2026.109289_bib47","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.jmgm.2026.109289_bib48","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"19","key":"10.1016\/j.jmgm.2026.109289_bib49","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1073\/pnas.0408037102","article-title":"Potential energy functions for atomic-level simulations of water and organic and biomolecular systems","volume":"102","author":"Jorgensen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2026.109289_bib50","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh ewald: an N\u00b7log(N) method for ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109289_bib51","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109289_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2026.109289_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/bip.10270","article-title":"Free energy calculations for theophylline binding to an RNA aptamer: Comparison of MM-PBSA and thermodynamic integration methods","volume":"68","author":"Gouda","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.jmgm.2026.109289_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109289_bib55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109289_bib56","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins Struct. Funct. Genet."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109289_bib57","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/j100058a043","article-title":"Accurate calculation of hydration free energies using macroscopic solvent models","volume":"98","author":"Sitkoff","year":"1994","journal-title":"J. Phys. Chem."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109289_bib58","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/ci1002679","article-title":"Docking studies on isoform-specific inhibition of phosphoinositide-3- kinases","volume":"50","author":"Sabbah","year":"2010","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109289_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/ml400378e","article-title":"Crystal structures of PI3K\u03b1 complexed with PI103 and its derivatives: new directions for inhibitors design","volume":"5","author":"Yanlong Zhao","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109289_bib60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acsmedchemlett.5b00025","article-title":"Discovery of a potent class of PI3K\u03b1 inhibitors with unique binding mode via encoded library technology (ELT)","volume":"6","author":"Yang","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109289_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21070857","article-title":"Molecular dynamics simulations to investigate the binding mode of the natural product liphagal with phosphoinositide 3-Kinase \u03b1","volume":"21","author":"Gao","year":"2016","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jmgm.2026.109289_bib62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10822-017-0092-8","article-title":"Discovering new PI3K\u03b1 inhibitors with a strategy of combining ligand-based and structure-based virtual screening","volume":"32","author":"Yu","year":"2018","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109289_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.22159\/ijap.2024v16i5.51514","article-title":"Molecular targets as potential Pi3K\u03b1 inhibitors against aggressive metastatic ductal and lobular carcinoma","volume":"16","author":"Mathew","year":"2024","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.jmgm.2026.109289_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-025-01616-w","article-title":"Exploring the anticancer potential of nitrated N-substituted-4-hydroxy-2-quinolone-3-carboxamides: synthesis, biological assessment, and computational analysis","volume":"19","author":"Islim","year":"2025","journal-title":"BMC Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib65","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1039\/D0NJ04216A","article-title":"Structural basis for tailor-made selective PI3K \u03b1\/\u03b2 inhibitors: a computational perspective","volume":"45","author":"Wang","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109289_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-83030-1","article-title":"Exploring target selectivity in designing and identifying PI3K\u03b1 inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach","volume":"15","author":"Halder","year":"2025","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.jmgm.2026.109289_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2022.2132293","article-title":"Development of PI3K \u03b1 inhibitors for tumor therapy","volume":"41","author":"Jia","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109289_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"34","key":"10.1016\/j.jmgm.2026.109289_bib70","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1021\/acs.jpcb.8b03655","article-title":"Assessing the performance of MM\/PBSA, MM\/GBSA, and QM-MM\/GBSA approaches on protein\/carbohydrate complexes: effect of implicit solvent models, QM methods, and entropic contributions","volume":"122","author":"Mishra","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2026.109289_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14756366.2021.2010729","article-title":"Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study","volume":"37","author":"Elmenier","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/j.jmgm.2026.109289_bib72","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1016\/j.bmc.2004.06.022","article-title":"Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold","volume":"12","author":"Knight","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib73","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/13543776.2021.1924150","article-title":"Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016-2020)","volume":"31","author":"Sabbah","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jmgm.2026.109289_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/ci900175n","article-title":"Class I phospho-inositide-3-kinases (PI3Ks) isoform-specific inhibition study by the combination of docking and molecular dynamics simulation","volume":"50","author":"Han","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109289_bib75","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/acs.jmedchem.0c01652","article-title":"Structure-based drug design and synthesis of PI3K\u03b1-Selective inhibitor (PF-06843195)","volume":"64","author":"Cheng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-025-01420-6","article-title":"In silico discovery of a novel potential allosteric PI3K\u03b1 inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma","volume":"19","author":"Jia","year":"2025","journal-title":"BMC Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108433","article-title":"Binding and selectivity studies of phosphatidylinositol 3-kinase (PI3K) inhibitors","volume":"121","author":"Al Hasan","year":"2023","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109289_bib78","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2026.109289_bib79","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1039\/c3sc50424g","article-title":"A concise enantioselective synthesis and cytotoxic evaluation of the anticancer rotenoid deguelin enabled by a tandem knoevenagel\/conjugate addition\/decarboxylation sequence","volume":"4","author":"Farmer Rl","year":"2013","journal-title":"Chem. Sci."},{"issue":"13","key":"10.1016\/j.jmgm.2026.109289_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17132232","article-title":"The PI3K\/Akt\/mTOR signaling pathway in triple-negative breast cancer: a resistance pathway and a prime target for targeted therapies","volume":"17","author":"Hassan","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jmgm.2026.109289_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s44442-025-00047-5","article-title":"PI3K\u03b1 inhibitors: structural advances, synthesis strategies, and anticancer potential","volume":"29","author":"Swati","year":"2025","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.jmgm.2026.109289_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106211","article-title":"Design, synthesis and biological evaluation of novel PI3K\u03b1 selective inhibitors","volume":"130","author":"wang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109289_bib85","doi-asserted-by":"crossref","DOI":"10.37349\/eds.2025.1008108","article-title":"Combinatorial and fragment-based in silico design of PI3K-alpha natural hybrid antagonists for breast cancer therapeutics","volume":"3","author":"Aggarwal","year":"2025","journal-title":"Explor Drug Sci"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632600015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632600015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:27:54Z","timestamp":1773959274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332632600015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":78,"alternative-id":["S109332632600015X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109289","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel PI3K\u03b1 inhibitor for breast cancer therapy via virtual screening method, molecular dynamics simulation and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109289"}}